FRONT-LINE TREATMENT OF BCR-ABL plus CHRONIC MYELOID LEUKEMIA WITH DASATINIB: A PROSPECTIVE MULTICENTRIC OBSERVATIONAL STUDY

被引：0

作者：

Castagnetti, F. ^{[1
]}

Gugliotta, G. ^{[1
]}

Breccia, M. ^{[2
]}

Sora, F. ^{[3
]}

Iurlo, A. ^{[4
]}

Gozzini, A. ^{[5
]}

Scortechini, A. R. ^{[6
]}

Luciano, L. ^{[7
]}

Stagno, F. ^{[8
]}

Malato, A. ^{[9
]}

Abruzzese, E. ^{[10
]}

Crugnola, M. ^{[11
,12
]}

Pregno, P. ^{[13
]}

Specchia, G. ^{[14
]}

Musto, P. ^{[15
]}

Cascavilla, N. ^{[16
]}

Tiribelli, M. ^{[17
]}

Bonifacio, M. ^{[18
]}

Galieni, P. ^{[19
]}

Palmieri, F. ^{[20
]}

Soverini, S. ^{[1
]}

Bochicchio, M. T. ^{[1
]}

Sica, S. ^{[3
]}

Foa, R. ^{[2
]}

Cavo, M. ^{[1
]}

Martinelli, G. ^{[1
]}

Saglio, G. ^{[21
]}

Pane, F. ^{[7
]}

Baccarani, M. ^{[22
]}

Rosti, G. ^{[1
]}

机构：

[1] Univ Bologna, Ist Ematol Seragnoli, Dipartimento Med Specialist Diagnost & Sperimenta, Policlin S Orsola Malpighi, Bologna, Italy

[2] Univ Roma La Sapienza, Policlin Umberto I, Unita Ematol, Dipartimento Biotecnol Cellulari & Ematol, Rome, Italy

[3] Univ Cattolica Sacro Cuore, Policlin A Gemelli, Unita Ematol, Rome, Italy

[4] Osped Maggiore Policlin, Unita Ematol, Fdn IRCCS Ca Granda, Milan, Italy

[5] AOU Careggi, Unita Ematol, Florence, Italy

[6] AOU Osped Riuniti, Unita Ematol, Ancona, Italy

[7] Univ Federico II, Unita Ematol, Naples, Italy

[8] Univ Catania, Unita Ematol Con Trapianto Midollo Osseo, AOU Policlin Vittorio Emanuele, Catania, Italy

[9] Osped Riuniti Villa Sofia Cervello, Unita Ematol, Palermo, Italy

[10] ASL Roma II, Unita Ematol, Osped S Eugenio, Rome, Italy

[11] Azienda Osped Univ Parma, Unita Ematol, Parma, Italy

[12] Azienda Osped Univ Parma, Ctr Trapianti Midollo Osseo, Parma, Italy

[13] Azienda Osped Univ Citta Salute & Sci, Unita Ematol, Turin, Italy

[14] Univ Bari, Unita Ematol, Osped Giovanni 23, Bari, Italy

[15] IRCCS Ctr Riferimento Oncol Basilicata, Unita Ematol, Rionero In Vulture, PZ, Italy

[16] IRCCS Casa Sollievo Sofferenza, Unita Ematol, San Giovanni Rotondo, FG, Italy

[17] Univ Udine, Unita Ematol, Udine, Italy

[18] Univ Verona, Unita Ematol, Verona, Italy

[19] Osped Mazzoni, Unita Ematol, Ascoli Piceno, Italy

[20] Osped SG Moscatti, Unita Ematol, Avellino, Italy

[21] Univ Torino, Unita Ematol, Osped Mauriziano, Turin, Italy

[22] Univ Bologna, Dipartimento Ematol & Oncol Med Seragnoli, Bologna, Italy

来源：

HAEMATOLOGICA | 2017年 / 102卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P102

引用

页码：92 / 92

页数：1

共 50 条

[1] First-Line Dasatinib in BCR-ABL1+Chronic Myeloid Leukemia in Early Chronic Phase: A Gimema Prospective Multicentric Observational Study
Castagnetti, Fausto
Gugliotta, Gabriele
Breccia, Massimo
Sora, Federica
Iurlo, Alessandra
Gozzini, Antonella
Scortechini, Anna Rita
Luciano, Luigia
Stagno, Fabio
Malato, Alessandra
Abruzzese, Elisabetta
Crugnola, Monica
Pregno, Patrizia
Specchia, Giorgina
Musto, Pellegrino
Cascavilla, Nicola
Tiribelli, Mario
Bonifacio, Massimiliano
Galieni, Piero
Palmieri, Fausto
Soverini, Simona
Bochicchio, Maria Teresa
Sica, Simona
Foa, Robin
Cavo, Michele
Martinelli, Giovanni
Saglio, Giuseppe
Pane, Fabrizio
Baccarani, Michele
Rosti, Gianantonio
BLOOD, 2017, 130
[2] DEEP MOLECULAR RESPONSE TO NILOTINIB AS FIRST-LINE TREATMENT OF BCR-ABL plus CHRONIC MYELOID LEUKEMIA
Castagnetti, F.
Gugliotta, G.
Breccia, M.
Rossi, G.
Stagno, F.
Turri, D.
Pregno, P.
Tiribelli, M.
Trabacchi, E.
Martino, B.
Carella, A. M.
Isidori, A.
Pierri, I.
Salvucci, M.
Specchia, G.
Levato, L.
Avanzini, P.
Capalbo, S.
Merli, A.
Maino, E.
Binotto, G.
Bochicchio, M. T.
Soverini, S.
Cavo, M.
Alimena, G.
Martinelli, G.
Saglio, G.
Pane, F.
Baccarani, M.
Rosti, G.
HAEMATOLOGICA, 2015, 100 : 55 - 55
[3] BCR-ABL Mutations in Chronic Myeloid Leukemia
Ernst, Thomas
La Rosee, Paul
Mueller, Martin C.
Hochhaus, Andreas
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 25 (05) : 997 - +
[4] BCR-ABL IN CHRONIC MYELOID-LEUKEMIA
不详
LANCET, 1986, 2 (8501): : 258 - 259
[5] Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations
Mueller, Martin C.
Cortes, Jorge E.
Kim, Dong-Wook
Druker, Brian J.
Erben, Philipp
Pasquini, Ricardo
Branford, Susan
Hughes, Timothy P.
Radich, Jerald P.
Ploughman, Lynn
Mukhopadhyay, Jaydip
Hochhaus, Andreas
BLOOD, 2009, 114 (24) : 4944 - 4953
[6] The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemia
El-Tanani, Mohamed
Nsairat, Hamdi
Matalka, Ismail I.
Lee, Yin Fai
Rizzo, Manfredi
Aljabali, Alaa A.
Mishra, Vijay
Mishra, Yachana
Hromic-Jahjefendic, Altijana
Tambuwala, Murtaza M.
PATHOLOGY RESEARCH AND PRACTICE, 2024, 254
[7] Identification of natural inhibitors of Bcr-Abl for the treatment of chronic myeloid leukemia
Parcha, Phanikrishna
Sarvagalla, Sailu
Madhuri, Bindu
Pajaniradje, Sankar
Baskaran, Vinitha
Coumar, Mohane Selvaraj
Rajasekaran, Baskaran
CHEMICAL BIOLOGY & DRUG DESIGN, 2017, 90 (04) : 596 - 608
[8] New BCR-ABL inhibitors in chronic myeloid leukemia
Rea, Delphine
ANNALS OF ONCOLOGY, 2019, 30
[9] Mutant BCR-ABL clones in chronic myeloid leukemia
Mathisen, Michael S.
Kantarjian, Hagop M.
Cortes, Jorge
Jabbour, Elias
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (03): : 347 - 349
[10] NK cell recognition of BCR-ABL plus chronic myeloid leukemia (CML) in vivo
Kijima, M. K. Mika
Held, W. H. Werner
ALLERGOLOGIE, 2011, 34 (02) : 90 - 90

← 1 2 3 4 5 →